Anavex Life Sciences
AVXL
#7563
Rank
S$0.50 B
Marketcap
S$5.70
Share price
-1.12%
Change (1 day)
-43.95%
Change (1 year)

Anavex Life Sciences (AVXL) - Total assets

Total assets on the balance sheet as of June 2025 : S$0.13 Billion

According to Anavex Life Sciences 's latest financial reports the company's total assets are S$0.13 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Anavex Life Sciences - Total assets on balance sheet (from 2005 to 2025)

Total assets by year

Year Total assets Change
2024-09-30S$0.17 B-17.4%
2023-09-30S$0.21 B-3.78%
2022-09-30S$0.21 B-0.15%
2021-09-30S$0.21 B365.67%
2020-09-30S$47.13 M34.65%
2019-09-30S$35.01 M-2.3%
2018-09-30S$35.83 M-5.3%
2017-09-30S$37.83 M191.96%
2016-09-30S$12.95 M-41.15%
2015-09-30S$22.02 M134.71%
2014-09-30S$9.38 M1799.88%
2013-09-30S$0.49 M2955.07%
2012-09-30S$0.01 M-93.87%
2011-09-30S$0.26 M-39.22%
2010-09-30S$0.43 M-25%
2009-09-30S$0.57 M5476.36%
2008-09-30S$0.01 M28005.4%
2007-09-30S$0 M-99.81%
2006-09-30S$0.01 M1101.59%
2005-09-30S$0 M-96.5%
2004-09-30S$0.04 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Ligand Pharmaceuticals
LGND
S$1.91 B 1,341.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$0.57 B 335.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$1.06 B 704.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$4.83 M-96.36%๐Ÿ‡บ๐Ÿ‡ธ USA